Tag: Syneos
Calling All Syneos Health, Inc. (SYNH) Investors: Contact Bronstein, Gewirtz &...
NEW YORK, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm,...
Syneos Health, Inc. (SYNH) Class Action Alert: Robbins LLP Reminds Investors...
Robbins LLP reminds investors that a shareholder filed a class action on behalf of purchasers of Syneos Health Companies Inc. SYNH common stock...
SYNH SHAREHOLDER ALERT: Jakubowitz Law Reminds Syneos Shareholders of a Lead...
NEW YORK, Aug. 4, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders...
Syneos Health to be Acquired by a Private Investment Consortium for...
Shareholders to Receive $43.00 Per Share in CashRepresents 24% Premium to Unaffected Stock PriceMORRISVILLE, N.C., May 10, 2023 (GLOBE NEWSWIRE) --...
Syneos Health Accelerates Decentralized Clinical Trial Delivery, Unveils New Collaboration with...
MORRISVILLE, N.C., June 21, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today expanded its...
Syneos Health to Present at Upcoming Investor Conferences
MORRISVILLE, N.C., May 21, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced that the...
Syneos Health Announces Pricing of Secondary Offering of Common Stock
MORRISVILLE, N.C., May 03, 2021 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully...
Syneos Health Announces Secondary Offering of Common Stock
MORRISVILLE, N.C., May 03, 2021 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully...
Syneos Health Reports First Quarter 2021 Results
Highlights Revenue of $1,208.7 million for the three months ended March 31, 2021, representing...